Track AKTS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
AKTS - Aktis Oncology, Inc. Common stock (AKTS) has a earnings per share of -$0.38, down 171.4% over the past year.
Latest EPS (Actual)
-$0.38
Beat Rate
25.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.33 | -$0.38 | Miss | -15.15% |
| Feb 2026 | -$1.15 | -$0.28 | Beat | +75.35% |
| Dec 2025 | $0.00 | -$16.06 | N/A | - |
| Nov 2024 | -$0.08 | -$0.04 | Beat | +50.00% |
| May 2024 | -$0.12 | -$0.14 | Miss | -16.67% |
| Feb 2024 | -$0.18 | -$0.19 | Miss | -5.56% |
| Nov 2023 | -$0.18 | -$0.27 | Miss | -50.00% |
| May 2023 | -$0.21 | -$0.20 | Meet | +4.76% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.